Merck & Co. is acquiring Verona Pharma PLC in a $10 billion deal that will expand the pharmaceutical giant’s portfolio of chronic obstructive pulmonary disease treatments with Verona Pharma’s ...
(NAPSI)—Chronic obstructive pulmonary disease (COPD) affects approximately 16 million Americans and can make even simple ...
Pulmonx Corporation (Nasdaq: LUNG) ('Pulmonx”), a global leader in minimally invasive treatments for lung disease, today ...
The best ways to get rid of phlegm, from using nasal sprays to taking the right OTC medications. Plus, they explain what ...
Among adults with COPD, those with vs. without cost-related nonadherence had worse symptom burden, health status and lung ...
After Asha Bhosle’s death from chest infection, doctors explain symptoms, warning signs, stages and treatment, especially ...
(Yicai) April 13 -- Shares of Haisco Pharmaceutical Group rose after the Chinese drugmaker granted US peer AbbVie the global ...